Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
Dopaminergic Modulation of Prefrontal Functions in Schizophrenic Patients: Adjuvant Therapy With Pergolide
Sponsor: Heidelberg University
Listed as NCT01066403, this NA trial focuses on Schizophrenia and remains completed. Sponsored by Heidelberg University, it has been updated 4 times since 2003, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Oct 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heidelberg University
- Stanley Medical Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .